Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariam Jouni

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biomolecules|January 23, 2024
Casein Kinase 1 Phosphomimetic Mutations Negatively Impact Connexin-43 Gap Junctions in Human Pluripotent Stem Cell-Derived CardiomyocytesRasha Al-Attar, Joseph Jargstorf, Rocco Romagnuolo, et al.
Journal of the American Heart Association|September 3, 2015
Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT SyndromeMariam Jouni, Karim Si-Tayeb, Zeineb Es-Salah-Lamoureux, et al.
Cell Reports|April 28, 2024
Independent compartmentalization of functional, metabolic, and transcriptional maturation of hiPSC-derived cardiomyocytesK Ashley Fetterman, Malorie Blancard, Davi M Lyra-Leite, et al.
Circulation Research|December 21, 2020
Structural and Functional Characterization of a Na<sub>v</sub>1.5-Mitochondrial CouplonMarta Pérez-Hernández, Alejandra Leo-Macias, Sarah Keegan, et al.
JACC. Cardiooncology|March 21, 2024
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related GenesHananeh Fonoudi, Mariam Jouni, Romina B Cejas, et al.
European Journal of Pharmacology|January 25, 2015
Thiazole derivatives as inhibitors of cyclooxygenases in vitro and in vivoGhewa A El-Achkar, Mariam Jouni, May F Mrad, et al.
Circulation|December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced CardiotoxicityTarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.
Journal of Molecular and Cellular Cardiology|September 4, 2016
HIV-Tat induces a decrease in I<sub>Kr</sub> and I<sub>Ks</sub>via reduction in phosphatidylinositol-(4,5)-bisphosphate availabilityZeineb Es-Salah-Lamoureux, Mariam Jouni, Olfat A Malak, et al.
Stem Cell Reports|January 14, 2020
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC CultureHui-Hsuan Kuo, Xiaozhi Gao, Jean-Marc DeKeyser, et al.
Cell Stem Cell|September 15, 2021
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapyTarek Magdy, Zhengxin Jiang, Mariam Jouni, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomolecules|January 23, 2024
Casein Kinase 1 Phosphomimetic Mutations Negatively Impact Connexin-43 Gap Junctions in Human Pluripotent Stem Cell-Derived CardiomyocytesRasha Al-Attar, Joseph Jargstorf, Rocco Romagnuolo, et al.
Journal of the American Heart Association|September 3, 2015
Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT SyndromeMariam Jouni, Karim Si-Tayeb, Zeineb Es-Salah-Lamoureux, et al.
Cell Reports|April 28, 2024
Independent compartmentalization of functional, metabolic, and transcriptional maturation of hiPSC-derived cardiomyocytesK Ashley Fetterman, Malorie Blancard, Davi M Lyra-Leite, et al.
Circulation Research|December 21, 2020
Structural and Functional Characterization of a Na<sub>v</sub>1.5-Mitochondrial CouplonMarta Pérez-Hernández, Alejandra Leo-Macias, Sarah Keegan, et al.
JACC. Cardiooncology|March 21, 2024
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related GenesHananeh Fonoudi, Mariam Jouni, Romina B Cejas, et al.
European Journal of Pharmacology|January 25, 2015
Thiazole derivatives as inhibitors of cyclooxygenases in vitro and in vivoGhewa A El-Achkar, Mariam Jouni, May F Mrad, et al.
Circulation|December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced CardiotoxicityTarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.
Journal of Molecular and Cellular Cardiology|September 4, 2016
HIV-Tat induces a decrease in I<sub>Kr</sub> and I<sub>Ks</sub>via reduction in phosphatidylinositol-(4,5)-bisphosphate availabilityZeineb Es-Salah-Lamoureux, Mariam Jouni, Olfat A Malak, et al.
Stem Cell Reports|January 14, 2020
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC CultureHui-Hsuan Kuo, Xiaozhi Gao, Jean-Marc DeKeyser, et al.
Cell Stem Cell|September 15, 2021
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapyTarek Magdy, Zhengxin Jiang, Mariam Jouni, et al.
Pageof 2